CAZZANIGA, GIOVANNI
CAZZANIGA, GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group
1997 Borkhardt, A; Cazzaniga, G; Viehmann, S; Valsecchi, M; Ludwig, W; Burci, L; Mangioni, S; Schrappe, M; Riehm, H; Lampert, F; Basso, G; Masera, G; Harbott, J; Biondi, A
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
1998 Van Dongen, J; Seriu, T; Panzer-Grumayer, E; Biondi, A; Pongers-Willemse, M; Corral, L; Stolz, F; Schrappe, M; Masera, G; Kamps, W; Gadner, H; Van Wering, E; Ludwig, W; Basso, G; De Bruijn, M; Cazzaniga, G; Hettinger, K; Van Der Does-Van Den Berg, A; Hop, W; Riehm, H; Bartram, C
Prenatal origin of acute lymphoblastic leukaemia in children
1999 Wiemels, J; Cazzaniga, G; Daniotti, M; Eden, O; Addison, G; Masera, G; Saha, V; Biondi, A; Greaves, M
Hereditary hyperferritinemia cataract syndrome: a de novo mutation in the iron responsive element of the L-ferritin gene
1999 Arosio, C; Fossati, L; Viganò, M; Trombini, P; Cazzaniga, G; Piperno, A
The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case
2001 Cazzaniga, G; Daniotti, M; Tosi, S; Giudici, G; Aloisi, A; Pogliani, E; Kearney, L; Biondi, A
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response
2002 Cazzaniga, G; Lanciotti, M; Rossi, V; Di Martino, D; Aricò, M; Valsecchi, M; Basso, G; Masera, G; Micalizzi, C; Biondi, A
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia
2003 Scrideli, C; Cazzaniga, G; Fazio, G; Pirola, L; Callegaro, A; Bassan, R; Rambaldi, A; Lo Nigro, L; Basso, G; Masera, G; Biondi, A
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR)
2003 Piazza, R; Magistroni, V; Tornaghi, L; Andreoni, F; Bungaro, S; Cazzaniga, G; Biondi, A; Pogliani, E; Varella Garcia, M; Corneo, G; GAMBACORTI PASSERINI, C
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia
2003 Arrigoni, P; Beretta, C; Silvestri, D; Rossi, V; Rizzari, C; Valsecchi, M; Cazzaniga, G; Biondi, A
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects
2003 van der Velden, V; Hochhaus, A; Cazzaniga, G; Szczepanski, T; Gabert, J; van Dongen, J
Standardization and quality control studies of 'real time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program
2003 Gabert, J; Beillard, E; van der Velden, V; Bi, W; Grimwade, D; Pallisgaard, N; Barbany, G; Cazzaniga, G; Cayuela, J; Cave, H; Pane, F; Aerts, J; De Micheli, D; Thirion, X; Pradel, V; Gonzalez, M; Viehmann, S; Malec, M; Saglio, G; van Dongen, J
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment
2004 Cazzaniga, G; Corradi, B; Piazza, R; Soverini, S; Martinelli, G; GAMBACORTI PASSERINI, C; Biondi, A
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias
2004 Hubner, S; Cazzaniga, G; Flohr, T; van der Velden, V; Konrad, M; Potschger, U; Basso, G; Schrappe, M; van Dongen, J; Bartram, C; Biondi, A; Panzer Grumayer, E
High clonal evolution rate in relapsing infant ALL patients
2004 Cazzaniga, G; Corral, L; Luciani, M; Songia, S; De Lorenzo, P; Spinelli, M; Lo Nigro, L; Basso, G; De Rossi, G; Biondi, A
Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood
2004 Maia, A; Tussiwand, R; Cazzaniga, G; Rebulla, P; Colman, S; Biondi, A; Greaves, M
SNP MINING BY NANOGEN DEVICE: A SENSITIVE TOOL FOR THE IDENTIFICATION OF BCR/ABL MUTATIONS IN PH+ PATIENTS
2004 Corradi, B; Piazza, R; Monn, K; Masera, G; GAMBACORTI PASSERINI, C; Biondi, A; Cazzaniga, G
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia
2004 Beretta, C; Gaipa, G; Rossi, V; Bernasconi, S; Spinelli, O; Dell'Oro, M; Rizzari, C; Rambaldi, A; Biondi, A; Cazzaniga, G
KIT activating mutations: Incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication
2004 Beghini, A; Ripamonti, C; Cairoli, R; Cazzaniga, G; Colapietro, P; Elice, F; Nadali, G; Grillo, G; Haas, O; Biondi, A; Morra, E; Larizza, L
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
2004 Tartaglia, M; Martinelli, S; Cazzaniga, G; Cordeddu, V; Iavarone, I; Spinelli, M; Palmi, C; Carta, C; Pession, A; Aricò, M; Masera, G; Basso, G; Sorcini, M; Gelb, B; Biondi, A
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection
2005 Gaipa, G; Basso, G; Maglia, O; Leoni, V; Faini, A; Cazzaniga, G; Bugarin, C; Veltroni, M; Michelotto, B; Ratei, R; Coliva, T; Valsecchi, M; Biondi, A; Dworzak, M